Familial Generalized and Partial Lipodystrophies Due to Rare Biallelic Variants in LMNA
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27041724 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Michael Hwang und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Lamin Type A, Lipodystrophy, Familial Partial. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Genetic lipodystrophies are a heterogeneous group of autosomal dominant and recessive disorders characterized by generalized or partial loss of body fat. Most patients with familial partial lipodystrophy (FPLD) have dominant inheritance with heterozygous pathogenic missense variants in LMNA. Here, we report two females with rare biallelic variants in LMNA presenting with divergent lipodystrophic phenotypes. Proband 1, a 32-year-old female, has near-generalized lipodystrophy (body fat 12.7%) due to compound heterozygous c.1745G>T (p.R582L) and c.1750C>T (p.R584C) LMNA variants. She was diagnosed with diabetes at age 17, hypertriglyceridemia at age 18, and metabolic dysfunction-associated steatotic liver disease (MASLD) at age 20. She was treated with metreleptin with only partial improvement in metabolic parameters. Her parents, heterozygous carriers of these variants, did not have lipodystrophy. Proband 2, a 35-year-old female, has partial lipodystrophy (body fat 21.2%) due to a homozygous c.1750C>T (p.R584C) LMNA variant. She was diagnosed with diabetes at age 19 and had a history of hypertriglyceridemia and mild hepatic steatosis. Her parents reportedly did not have lipodystrophy. These cases highlight the expression of LMNA variants in the homozygous or compound heterozygous state, manifesting in near-generalized and partial loss of body fat with distinct phenotypic heterogeneity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
- Eugene McDermott Center for Human Growth and Development, UT Southwestern Medical Center, Dallas, TX 75390, USA.
- Lyda Hill Department of Bioinformatics, UT Southwestern Medical Center, Dallas, TX 75390, USA.
- O'Donnell School of Public Health, UT Southwestern Medical Center, Dallas, TX 75390, USA.
- Section of Nutrition and Metabolic Diseases, Division of Endocrinology, Department of Internal Medicine, Center for Human Nutrition, UT Southwestern Medical Center, Dallas, TX 75390, USA.
ORCID-Profile: Michael Hwang, Chao Xing
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Hwang, M., Worthy, C., Cochran, E., Startzell, M., Muniyappa, R., Xing, C., Garg, A., & Brown, R. J. (2026). Familial Generalized and Partial Lipodystrophies Due to Rare Biallelic Variants in LMNA. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27041724
Vancouver
Hwang M, Worthy C, Cochran E, Startzell M, Muniyappa R, Xing C, et al. Familial Generalized and Partial Lipodystrophies Due to Rare Biallelic Variants in LMNA. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27041724
BibTeX
@article{Hwang2026,
author = {Hwang, Michael and Worthy, Charlita and Cochran, Elaine and Startzell, Megan and Muniyappa, Ranganath and Xing, Chao and Garg, Abhimanyu and Brown, Rebecca J},
title = {Familial Generalized and Partial Lipodystrophies Due to Rare Biallelic Variants in LMNA},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27041724}
}
EUVIMED